GILD Dividend History & Yield
Gilead Sciences, Inc. · NasdaqGS
Upcoming dividend payments
| Ex-date | Pay date | Per share | Per 100 shares | Status |
|---|---|---|---|---|
| Tue, Sep 15, 2026 (in 7 days) | Sep 29, 2026 | $0.82 | $82.00 | Declared |
| Tue, Dec 15, 2026 (in 98 days) | Dec 29, 2026 | $0.82 | $82.00 | Estimated |
| Tue, Mar 16, 2027 (in 189 days) | Mar 30, 2027 | $0.82 | $82.00 | Estimated |
| Tue, Jun 15, 2027 (in 280 days) | Jun 29, 2027 | $0.82 | $82.00 | Estimated |
Estimated dates and amounts are projected from GILD's recent payment pattern and will be replaced by declared figures when the company announces them. Total over the next 12 months: about $3.28 per share.
Dividend payment history
Last 40 payments per share. RegularSpecial
Annual dividends per share
How much GILD do you need for monthly income?
| Target income | Shares needed | Capital at today's price | Per year |
|---|---|---|---|
| $100 / month | 366 | $53,649 | $1,200 |
| $500 / month | 1,830 | $268,244 | $6,000 |
| $1,000 / month | 3,659 | $536,488 | $12,000 |
Based on the forward yield of 2.24%. $10,000 in GILD would currently pay about $224 a year ($19 a month on average). Model reinvestment and growth →
GILD dividend history
| Ex-date | Pay date | Amount | Change |
|---|---|---|---|
| Jun 15, 2026 | Jun 29, 2026 | $0.82 | +0.0% |
| Mar 13, 2026 | Mar 30, 2026 | $0.82 | +3.8% |
| Dec 15, 2025 | Dec 30, 2025 | $0.79 | +0.0% |
| Sep 15, 2025 | Sep 29, 2025 | $0.79 | +0.0% |
| Jun 13, 2025 | Jun 27, 2025 | $0.79 | +0.0% |
| Mar 14, 2025 | Mar 28, 2025 | $0.79 | +2.6% |
| Dec 13, 2024 | Dec 30, 2024 | $0.77 | +0.0% |
| Sep 13, 2024 | Sep 27, 2024 | $0.77 | +0.0% |
| Jun 14, 2024 | Jun 27, 2024 | $0.77 | +0.0% |
| Mar 14, 2024 | Mar 28, 2024 | $0.77 | +2.7% |
| Dec 14, 2023 | Dec 28, 2023 | $0.75 | +0.0% |
| Sep 14, 2023 | Sep 28, 2023 | $0.75 | +0.0% |
| Jun 14, 2023 | Jun 29, 2023 | $0.75 | +0.0% |
| Mar 14, 2023 | Mar 30, 2023 | $0.75 | +2.7% |
| Dec 14, 2022 | Dec 29, 2022 | $0.73 | +0.0% |
| Sep 14, 2022 | Sep 29, 2022 | $0.73 | +0.0% |
| Jun 14, 2022 | Jun 29, 2022 | $0.73 | +0.0% |
| Mar 14, 2022 | Mar 30, 2022 | $0.73 | +2.8% |
| Dec 14, 2021 | Dec 30, 2021 | $0.71 | +0.0% |
| Sep 14, 2021 | Sep 29, 2021 | $0.71 | +0.0% |
| Jun 14, 2021 | Jun 29, 2021 | $0.71 | +0.0% |
| Mar 12, 2021 | Mar 30, 2021 | $0.71 | +4.4% |
| Dec 14, 2020 | Dec 30, 2020 | $0.68 | +0.0% |
| Sep 14, 2020 | Sep 29, 2020 | $0.68 | +0.0% |
| Jun 11, 2020 | Jun 29, 2020 | $0.68 | +0.0% |
| Mar 12, 2020 | Mar 30, 2020 | $0.68 | +7.9% |
| Dec 12, 2019 | Dec 30, 2019 | $0.63 | +0.0% |
| Sep 12, 2019 | Sep 27, 2019 | $0.63 | +0.0% |
| Jun 13, 2019 | Jun 27, 2019 | $0.63 | +0.0% |
| Mar 14, 2019 | Mar 28, 2019 | $0.63 | +10.5% |
| Dec 13, 2018 | Dec 28, 2018 | $0.57 | +0.0% |
| Sep 13, 2018 | Sep 27, 2018 | $0.57 | +0.0% |
| Jun 14, 2018 | Jun 28, 2018 | $0.57 | +0.0% |
| Mar 15, 2018 | Mar 29, 2018 | $0.57 | +9.6% |
| Dec 14, 2017 | Dec 28, 2017 | $0.52 | +0.0% |
| Sep 14, 2017 | Sep 28, 2017 | $0.52 | +0.0% |
| Jun 14, 2017 | Jun 29, 2017 | $0.52 | +0.0% |
| Mar 14, 2017 | Mar 30, 2017 | $0.52 | +10.6% |
| Dec 13, 2016 | Dec 29, 2016 | $0.47 | +0.0% |
| Sep 14, 2016 | Sep 29, 2016 | $0.47 | +0.0% |
| Jun 14, 2016 | Jun 29, 2016 | $0.47 | +9.3% |
| Mar 14, 2016 | Mar 30, 2016 | $0.43 | +0.0% |
| Dec 14, 2015 | Dec 30, 2015 | $0.43 | +0.0% |
| Sep 14, 2015 | Sep 29, 2015 | $0.43 | +0.0% |
| Jun 12, 2015 | Jun 29, 2015 | $0.43 | — |
Payout risk check
GILD scores 0/100 on our yield-trap heuristic (low risk).
No warning flags: the payout ratio, yield level, 5-year cut history and price trend all look ordinary.
This is a rule-based screen computed from public data, not a rating or a recommendation. Read our guide to yield traps for what the signals mean.
About Gilead Sciences, Inc.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Descovy, Genvoya, Odefsey, Sunlenca, Symtuza, and YeztugoFor the treatment of HIV-1 infection in patients. It also provides Epclusa, Livdelzi, and Vemlidy to treat chronic hepatitis C virus, primary biliary cholangitis, and chronic hepatitis B virus; Tecartus, a T-cell therapy for the treatment of adult patients; Trodelvy, an injection for intravenous use; and Yescarta, a suspension for intravenous infusion, is a CAR T-cell therapy for the treatment of adult patients.
Sector: Healthcare. Industry: Drug Manufacturers - General. First dividend on our records: Jun 12, 2015. 45 payments tracked.
GILD dividend FAQ
When is GILD's next ex-dividend date?
GILD's next ex-dividend date is Sep 15, 2026 (in 7 days, declared by the company). You must own the shares before that date to receive the payment of about $0.82 per share, expected on Sep 29, 2026.
How often does GILD pay dividends?
GILD pays dividends every quarter, 4 times a year. The most recent payment was $0.82 per share with an ex-date of Jun 15, 2026.
What is GILD's dividend yield?
GILD's trailing 12-month dividend yield is 2.20%, based on $3.22 per share paid over the last year and a share price of $146.64. The forward yield, using the indicated annual rate of $3.28 per share, is 2.24%.
How much does GILD pay per share?
GILD pays about $0.82 per share each quarter, which works out to roughly $3.28 per share a year. 100 shares would collect about $328.00 a year.
Has GILD grown or cut its dividend?
GILD has raised its annual dividend for 10 consecutive years. Over the last 5 years the regular payout has grown at 3.0% a year (+3.2% over the last year). There has been no cut to a regular payment in the last 5 years.
How many shares of GILD do I need to earn $100 a month?
At the current forward yield of 2.24%, you would need about 366 shares of GILD (roughly $53,649 invested at today's price) to collect $1,200 a year, or $100 a month on average, before taxes. Payments arrive every quarter, so the monthly figure is an average.
Similar dividend stocks
| Symbol | Type | Price | TTM yield | Annual / share | Frequency | Next ex-date | Trend |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly and Company | Stock | $1,123.91 | 0.60% | $6.92 | Quarterly | Nov 13 Est. | |
| JNJJohnson & Johnson | Stock | $269.17 | 1.96% | $5.36 | Quarterly | Nov 24 Est. | |
| ABBVAbbVie Inc. | Stock | $248.86 | 2.74% | $6.92 | Quarterly | Oct 14 Est. | |
| MRKMerck & Co., Inc. | Stock | $148.46 | 2.26% | $3.40 | Quarterly | Sep 15 Declared | |
| UNHUnitedHealth Group Incorporated | Stock | $400.84 | 2.23% | $9.28 | Quarterly | Sep 14 Declared | |
| NVSNovartis AG | Stock | $137.70 | 3.47% | $4.773 | Annual | Mar 11 Est. | |
| AZNAstraZeneca PLC | Stock | $160.04 | 1.35% | $4.306 | Semi-annual | Feb 18 Est. | |
| TMOThermo Fisher Scientific Inc. | Stock | $603.02 | 0.30% | $1.88 | Quarterly | Sep 15 Declared |